Topic: Seamus Fernandez

Drug and Biotech Stocks to Buy Now

Biotech stocks are a risky bet in the best market. Like an aging ex-high school jock, big drug companies' best days are behind them. (See Pfizer...
Unfazed by government warnings, many women desire breast implants. That's the word from plastic surgeons recently surveyed about their expectations...
Executives. . Jan Lundberg - Executive Vice President of Science & Technology and President of Lilly Research Laboratories. . Derica Rice - Chief ...
The news isn't good for Bristol-Myers Squibb (BMY) and AstraZeneca (AZN) as they head into a Food and Drug Administration advisory panel next week...
Even after Merck (MRK) won unanimous approval for its experimental hepatitis C drug, analysts say it still appears that rival Vertex...
Merck (MRK) appears to have a good start to a critically important week for its experimental hepatitis C treatment Boceprevir.. A Food and Drug...
Those cuts and kinder year-over-year comparisons played a role in lifting third-quarter profits, but some companies also showed signs of real growth, says David Kelson, a portfolio manager at Talon Asset Management. Consumer spending may have become an unsustainably large portion of ...

Cost cuts at Big Pharma fail to excite

NEW YORK (Reuters) - Cost cuts helped drugmakers shore up profits in the third quarter, but concerns over sustainable revenue growth continues to worry investors.Merck & "Shares of Merck were down 1.3 percent in morning trading in New York after falling as ...

Pfizer halts enrollment in lung cancer trial

NEW YORK (Reuters) - Pfizer Inc has halted patient enrollment in a late-stage lung cancer trial of its experimental drug, figitumumab, for safety reasons, the drugmaker said on Friday.The halt was recommended by independent safety monitors overseeing the study. As of Sept ...
Pfizer Inc has halted patient enrollment in a late-stage lung cancer trial of its experimental drug, figitumumab, for safety reasons, the drugmaker said on Friday. Pfizer said currently enrolled patients may continue their treatment in consultation with their physicians. The enrollment halt ...